Toward a new anti-inflammatory and analgesic agent.
Regoli
D
D
Department of Clinical and Experimental Medicine, Section of Pharmacology, Medical School, University of Ferrara, Ferrara 44100, Italy.
D000700:Analgesics; D000818:Animals; D000893:Anti-Inflammatory Agents; D065168:Bradykinin Receptor Antagonists; D002211:Capsaicin / Q000494:pharmacology; D051546:Cyclooxygenase 2; D005557:Formaldehyde / Q000494:pharmacology; D007249:Inflammation / Q000209:etiology*; D007375:Interleukin-1 / Q000378:metabolism; D007527:Isoenzymes / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D010146:Pain / Q000209:etiology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D043783:Receptor, Bradykinin B1; D018002:Receptors, Bradykinin / Q000235:genetics / Q000378:metabolism*; D018040:Receptors, Neurokinin-1 / Q000378:metabolism; D012772:Shock, Septic / Q000209:etiology*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D065168:Bradykinin Receptor Antagonists; D007375:Interleukin-1; D007527:Isoenzymes; D043783:Receptor, Bradykinin B1; D018002:Receptors, Bradykinin; D018040:Receptors, Neurokinin-1; D005557:Formaldehyde; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases; D002211:Capsaicin